Miguel Servet Researcher Position

Job Details

IRBLleida is seeking outstanding researchers interested in developing an independent career in biomedical research and applying for a Miguel Servet researcher position under the 2027 call of the Instituto de Salud Carlos III (ISCIII) within the AES program.

The selected candidate will be prioritized through IRBLleida s internal selection process to apply for a Miguel Servet position in the 2027 AES call. This opportunity is aimed at researchers with a strong scientific track record and the potential to establish an independent research program, lead innovative research projects, and contribute to the scientific development of the institute.

As part of the internal prioritization process, candidates will be assessed based on their research trajectory, scientific achievements, leadership potential, and the added value of their proposed research to IRBLleida. Particular consideration will be given to their potential to establish new collaborations, bring complementary expertise and methodologies, develop new research opportunities, and strengthen the institute s research capacity.

The successful candidate will join IRBLleida s multidisciplinary research environment and receive institutional support in preparing their Miguel Servet proposal, in accordance with the eligibility criteria and conditions established in the official 2027 AES call.

All those considering applying for a Miguel Servet contract under the AES 2027 call must submit an expression of interest to projects@irblleida.cat.

Expression of interest submission deadline: January 12, 2027, at 3:00 p.m. (CET).

The required documentation must be submitted through the link provided for this purpose in the External Calls section of the IRBLleida website, using this Form.

For further information, please consult the Guidelines for the Prioritization Process.

Submission of documents for prioritization: unit February 2nd , 2027, at 3:00 p.m.

Company

The Institute for Research in Biomedicine of Lleida (IRBLleida) has been a pioneering institution in biomedical research and innovation since 2004. With a multidisciplinary team of more than 600 people, we work in key areas such as oncology, neuroscience, cardiology and endocrinology, among others. We foster collaboration with national and international institutions to share knowledge and cutting-edge technologies. In addition, we are committed to the training of new talent and constant innovation in biomedicine. Our goal is to understand the fundamental mechanisms of human pathologies and to generate scientific discoveries that transform people's health and quality of life.